ID

33367

Description

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Keywords

  1. 11/6/18 11/6/18 -
  2. 12/6/18 12/6/18 -
Copyright Holder

GSK group of companies

Uploaded on

December 6, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Study conclusion

  1. StudyEvent: ODM
    1. Study conclusion
Study conclusion details
Description

Study conclusion details

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Date of subject completion or withdrawal
Description

Date of subject completion or withdrawal

Data type

date

Alias
UMLS CUI [1]
C2983670
Was the subject withdrawn from the study?
Description

Was the subject withdrawn from the study?

Data type

boolean

Alias
UMLS CUI [1]
C0422727
If YES, complete primary reason for withdrawal
Description

If YES, complete primary reason for withdrawal

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C0392360
1. Adverse event
Description

record details on AE or SAE forms as appropriate)

Data type

boolean

Alias
UMLS CUI [1]
C0877248
2. Lack of efficacy
Description

Check all that apply. If none, select "No Subreasons"

Data type

text

Alias
UMLS CUI [1]
C0235828
3. Protocol Deviation
Description

Check all that apply. If none, select "No Subreasons"

Data type

text

Alias
UMLS CUI [1]
C1705236
4. Subject reached protocol defined stopping criteria
Description

4. Subject reached protocol defined stopping criteria

Data type

text

Alias
UMLS CUI [1,1]
C2746065
UMLS CUI [1,2]
C0243161
5. Study closed/terminated
Description

5. Study closed/terminated

Data type

boolean

Alias
UMLS CUI [1]
C2348570
6. Lost to Follow-Up
Description

6. Lost to Follow-Up

Data type

boolean

Alias
UMLS CUI [1]
C1302313
7. Investigator discretion, specify
Description

Select this reason if none of the other primary reasons are appropriate

Data type

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C0022423
UMLS CUI [1,3]
C2348235
8. Withdrew consent, specify
Description

Select this reason if none of the other primary reasons are appropriate

Data type

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2348235

Similar models

Study conclusion

  1. StudyEvent: ODM
    1. Study conclusion
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Study conclusion details
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item Group
If YES, complete primary reason for withdrawal
C0422727 (UMLS CUI-1)
C0392360 (UMLS CUI-2)
1. Adverse event
Item
1. Adverse event
boolean
C0877248 (UMLS CUI [1])
Item
2. Lack of efficacy
text
C0235828 (UMLS CUI [1])
Code List
2. Lack of efficacy
CL Item
No subreasons (1)
CL Item
Exacerbation (2)
Item
3. Protocol Deviation
text
C1705236 (UMLS CUI [1])
Code List
3. Protocol Deviation
CL Item
No subreasons (1)
CL Item
Pregnancy (2)
CL Item
Lack of adherence (3)
CL Item
Prohibited medication use (4)
Item
4. Subject reached protocol defined stopping criteria
text
C2746065 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Code List
4. Subject reached protocol defined stopping criteria
CL Item
Yes (1)
CL Item
No (2)
CL Item
Liver function test abnormality (3)
5. Study closed/terminated
Item
5. Study closed/terminated
boolean
C2348570 (UMLS CUI [1])
6. Lost to Follow-Up
Item
6. Lost to Follow-Up
boolean
C1302313 (UMLS CUI [1])
7. Investigator discretion, specify
Item
7. Investigator discretion, specify
text
C0008961 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
8. Withdrew consent, specify
Item
8. Withdrew consent, specify
text
C1707492 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial